Stock screenerAll disclosures →
EDGAR →
IVVD
Conviction 32HealthcareScan · Thu, Jun 25, 2026IVVD$0.8749-6.31%
ResistanceSupportVol 14Vol MA14 7.5M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price0.8749
Change-6.31%
Gap-0.32%
Rel volume2.21×
Avg volume6.1M
Avg $ vol5.7M
SMA 200.9841
SMA 501.23
SMA 2001.70
Price vs 50-28.98%
Price vs 200-48.47%
MA stackbearish
50/200 cross—
Supertrenddown · 1.13
RSI (14)37
MACD hist0.01
MACD crossbull · 4d
Stoch %K / %D37 / 43
ADX (14)26
+DI / −DI15 / 25
RSI divergence—
MACD divergenceBullish
ATR %+11.50%
ADR %10.29%
52w high2.88
52w low0.5201
From 52w high-69.62%
Above 52w low+68.22%
New 52w highNo
SqueezeOff
Bollinger width48.70%
%B0.27
Donchian pos28.11%
Donchian high1.25
Donchian low0.7282
AVWAP (52w high)1.78
vs AVWAP high-50.82%
AVWAP (52w low)1.64
vs AVWAP low-46.77%
OBV trendFlat
Chaikin MF (20)-0.13
Today vs 20d2.21×
Avg vol (14d)7.5M
Avg vol (20d)6.1M
Avg $ vol (20d)5.7M
Market cap257.75M
RS 3m (vs SPY)-46.96%
RS 6m (vs SPY)-67.14%
RS line new highNo
Trend template3/8
Technical rank5.8
1 week-6.05%
1 month-20.46%
3 months-43.92%
6 months-69.62%
1 year+16.65%
YTD-65.00%
P/E-4.91
P/B1.27
P/S4.82
P/FCF-4.42
EPS-0.3000
Div yield—
ROE-25.85%
ROA-21.71%
Debt/Eq—
Current6.47
EV/EBITDA—
Gross margin—
Net margin-98.25%
Rev growth110.47%
EPS growth69.11%
Price target10.00
Target upside1042.99%
Analyst ratingBuy
Institutional85.28%
Ent. value73.6M
Revenue13.74M
Net income-41.4M
Gross profit—
Free cash flow-58.29M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out294.61M
Employees122
ListedFri, Aug 6, 2021
Free float155.54M
Float %66.7%
Short interest30.93M
Days to cover10.6d
Short volume51.0%
Squeeze score87 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.13 vs −$0.08
Last surprise-62.5% miss
Setup gradeD
Conviction32 / 100
Pattern quality—
Tech rank5.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.58
Support0.8741
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in IVVD
No recent disclosed trades by Congress in IVVD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IVVD · 7 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BOLNO PAUL Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 32.88K | $0 | 2026-05-19 | 2026-05-21 |
MCGUIRE TERRANCE Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
Royan Ajay Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
Berry Tamsin Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
M28 Capital Management LP Insider · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
Elia Marc Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
MCLAUGHLIN KEVIN F Director · Stock Option (Right to Buy) · 2026-05-19 | Grant | 50K | $0 | 2026-05-19 | 2026-05-21 |
SEC filings
EDGAR filings in IVVD
No recent SEC filings on file for IVVD.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.